IRC
INSM icon

Investors Research Corp’s Insmed INSM Stock Holding History

Investors Research Corp’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.71K Hold
16
– – ﹤0.01% 699
2026
Q1 		$2.62K Buy
+16
New +$2.46K ﹤0.01% 679

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Investors Research Corp's INSM Position: Q2 2026 in Review

Investors Research Corp held its Insmed (INSM) position steady in Q2 2026 at 16 shares worth $1.71K. The position accounts for ﹤0.01% of the portfolio, ranked #699.

Investors Research Corp first reported a position in INSM in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.62K in Q1 2026. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Investors Research Corp held 16 shares of Insmed worth $1.71K as of Q2 2026.
  • Investors Research Corp left its Insmed share count unchanged in Q2 2026.
  • Insmed made up ﹤0.01% of Investors Research Corp's portfolio in Q2 2026, its #699 holding.
  • Investors Research Corp first reported a position in Insmed in Q1 2026 and has held it in 2 quarters since.
  • Investors Research Corp's Insmed position peaked at $2.62K in Q1 2026.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.